全文获取类型
收费全文 | 45981篇 |
免费 | 3523篇 |
国内免费 | 648篇 |
专业分类
耳鼻咽喉 | 560篇 |
儿科学 | 1217篇 |
妇产科学 | 738篇 |
基础医学 | 3531篇 |
口腔科学 | 1516篇 |
临床医学 | 4764篇 |
内科学 | 5889篇 |
皮肤病学 | 648篇 |
神经病学 | 8095篇 |
特种医学 | 845篇 |
外国民族医学 | 291篇 |
外科学 | 2172篇 |
综合类 | 6373篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 5277篇 |
眼科学 | 274篇 |
药学 | 4437篇 |
10篇 | |
中国医学 | 2174篇 |
肿瘤学 | 1337篇 |
出版年
2024年 | 76篇 |
2023年 | 771篇 |
2022年 | 761篇 |
2021年 | 1621篇 |
2020年 | 1578篇 |
2019年 | 1515篇 |
2018年 | 1584篇 |
2017年 | 1406篇 |
2016年 | 1366篇 |
2015年 | 1234篇 |
2014年 | 5663篇 |
2013年 | 5368篇 |
2012年 | 3461篇 |
2011年 | 3370篇 |
2010年 | 4431篇 |
2009年 | 4164篇 |
2008年 | 2384篇 |
2007年 | 1297篇 |
2006年 | 1099篇 |
2005年 | 875篇 |
2004年 | 774篇 |
2003年 | 792篇 |
2002年 | 617篇 |
2001年 | 455篇 |
2000年 | 403篇 |
1999年 | 355篇 |
1998年 | 348篇 |
1997年 | 306篇 |
1996年 | 233篇 |
1995年 | 216篇 |
1994年 | 191篇 |
1993年 | 168篇 |
1992年 | 183篇 |
1991年 | 128篇 |
1990年 | 131篇 |
1989年 | 76篇 |
1988年 | 95篇 |
1987年 | 84篇 |
1986年 | 71篇 |
1985年 | 104篇 |
1984年 | 73篇 |
1983年 | 56篇 |
1982年 | 51篇 |
1981年 | 44篇 |
1980年 | 33篇 |
1979年 | 35篇 |
1978年 | 32篇 |
1977年 | 27篇 |
1976年 | 15篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
《Actas dermo-sifiliográficas》2022,113(2):141-149
Hair shaft disorders, involving dysplastic abnormalities in the shaft, may be either congenital or acquired. Two large categories have been defined according to the presence or not of hair fragility. A diagnosis can usually be made after taking a thorough medical history and performing a physical examination. Trichoscopy has become a useful, cost-effective tool in recent years, particularly for examining the hair of children, because it facilitates inspection without removal of hairs. Structural abnormalities in the hair shaft are sometimes clues to the diagnosis of more complex diseases in which early treatment can improve prognosis. This review describes key features that enable the diagnosis of the most common hair shaft disorders and discusses the various treatments currently available. 相似文献
53.
54.
《Surgery (Oxford)》2022,40(11):731-737
Disorders of sex development (DSD) occur in 1–2/10,000 live births, with a specific molecular diagnosis only possible in 20% of cases. Presentation is usually at birth, and gender assignment must be avoided before review by an expert multidisciplinary team. Initial investigations allow a working diagnosis to be made within 48 hr. In 46,XY DSD, surgery may be necessary to correct hypospadias, reposition or remove undescended testes, and remove symptomatic Müllerian remnants. In 46,XX DSD, feminizing surgery is performed less frequently than in the past, but genitoplasty may still be indicated. Psychosocial support is required to promote positive adaptation as gender dissatisfaction can occur in certain conditions. Long-term outcome data are sparse. 相似文献
55.
56.
57.
IntroductionTo disentangle the association between impulsive and compulsive behaviors (ICBs), health-related quality of life (HRQOL), satisfaction with life (SwL), and caregiver distress in dyads of people with Parkinson's disease (PwP) and caregivers.MethodsData used in this study were obtained from the ongoing Norwegian ParkWest study, a population-based longitudinal cohort study of the incidence, neurobiology and prognosis of PD in Western Norway. One hundred and one dyads of PwP free of dementia and their caregivers were included 5 years after PD diagnosis and inclusion in the ParkWest study. Standardized clinical rating scales were used to evaluate ICBs, HRQOL, SwL and caregiver distress.ResultsOf 101 PwP-caregiver dyads, self-reported ICBs were seen in 33% of PwP and only caregiver-reported ICBs in 12% of PwP. PwP-reported ICBs were associated with poorer HRQOL and SwL, whereas ICBs reported by caregivers only were associated with increased caregiver distress, but not poorer HRQOL or SwL in PwP.ConclusionsICBs have adverse effects on HRQOL, SwL and caregiver distress. These findings underpin the need for proper identification and management of ICBs in PwP. 相似文献
58.
59.
《Revista brasileira de otorrinolaringologia (English ed.)》2019,85(5):642-663
IntroductionPossible associations between Zika virus infection and hearing loss were observed during the epidemic in the Americas.ObjectiveTo describe the auditory alterations, pathogenesis and recommendations for follow-up in individuals with prenatal or acquired Zika virus infection.MethodsBibliographic research conducted in March/2018–April/2019 at the main available databases. Article selection, data extraction and quality evaluation were carried out by two independent reviewers. Studies containing auditory evaluation of patients with congenital or acquired Zika virus infection; and/or hypotheses or evidences on the pathophysiology of auditory impairment associated with Zika virus; and/or recommendations on screening and follow-up of patients with auditory impairment by Zika virus were included.ResultsA total of 27 articles were selected. Sensorineural and transient hearing loss were reported in six adults with acquired Zika virus infection. Of the 962 studied children, 482 had microcephaly and 145 had diagnostic confirmation of Zika virus; 515 of the 624 children with auditory evaluation performed only screening tests with otoacoustic emissions testing and/or automated click-stimuli auditory brainstem response testing. Studies in prenatally exposed children were very heterogeneous and great variations in the frequency of altered otoacoustic emissions and automated click-stimuli auditory brainstem response occurred across the studies. Altered otoacoustic emissions varied from 0% to 75%, while altered automated click-stimuli auditory brainstem response varied from 0% to 29.2%. Sensorineural, retrocochlear or central origin impairment could not be ruled out. One study with infected mice found no microscopic damage to cochlear hair cells. Studies on the pathogenesis of auditory changes in humans are limited to hypotheses and recommendations still include points of controversy.ConclusionThe available data are still insufficient to understand the full spectrum of the involvement of the auditory organs by Zika virus, the pathogenesis of this involvement or even to confirm the causal association between auditory involvement and virus infection. The screening and follow-up recommendations still present points of controversy. 相似文献
60.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献